Cargando…
Cellular and molecular basis of RV hypertrophy in congenital heart disease
RV hypertrophy (RVH) is one of the triggers of RV failure in congenital heart disease (CHD). Therefore, improving our understanding of the cellular and molecular basis of this pathology will help in developing strategic therapeutic interventions to enhance patient benefit in the future. This review...
Autores principales: | Iacobazzi, D, Suleiman, M-S, Ghorbel, M, George, SJ, Caputo, M, Tulloh, RM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717403/ https://www.ncbi.nlm.nih.gov/pubmed/26516182 http://dx.doi.org/10.1136/heartjnl-2015-308348 |
Ejemplares similares
-
Changes in contractile protein expression are linked to ventricular stiffness in infants with pulmonary hypertension or right ventricular hypertrophy due to congenital heart disease
por: Bond, Andrew R, et al.
Publicado: (2018) -
Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis
por: Samak, Mostafa, et al.
Publicado: (2016) -
Graft rejection in paediatric congenital heart disease
por: Harris, Amy G., et al.
Publicado: (2023) -
Accelerated Cardiac Aging in Patients With Congenital Heart Disease
por: Iacobazzi, Dominga, et al.
Publicado: (2022) -
Corrigendum: Accelerated cardiac aging in patients with congenital heart disease
por: Iacobazzi, Dominga, et al.
Publicado: (2022)